Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 239-555-0 | CAS number: 15520-05-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2012-02-13 to 2012-05-03
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 012
- Report date:
- 2012
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- (Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit, München, Germany)
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- The test material has detergent properties. Substances of this type regularly show false positive results in the LLNA in mice. Therefore another method was selected.
Test material
- Reference substance name:
- 2,2'-(octylimino)bisethanol
- EC Number:
- 239-555-0
- EC Name:
- 2,2'-(octylimino)bisethanol
- Cas Number:
- 15520-05-5
- Molecular formula:
- C12H27NO2
- IUPAC Name:
- 2-[(2-hydroxyethyl)(octyl)amino]ethan-1-ol
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- female
- Details on test animals and environmental conditions:
- - Semi barrier in an air-conditioned room
- Temperature: 22 +/- 3 °C
- Relative humidity: 55 +/- 10%
- Artificial light, sequence being 12 hours light, 12 hours dark
- Air change: at least 10 x / hour
- Free access to autoclaved hay and to Altromin 3122 maintenance diet for guinea pigs
(preliminary test and main study: lot no. 0930), rich in crude fibre
- Free access to tap water (drinking water, municipal residue control, microbiological controls at regular intervals)
- The animals were kept in groups in Terluran - cages on Altromin saw fibre bedding
(preliminary test: lot no. 110811, main study: lot no. 061211)
- Certificates of food, water and bedding are filed at BSL BIOSERVICE
- Adequate acclimatisation period (at least five days) under laboratory conditions
Study design: in vivo (non-LLNA)
Induction
- Route:
- intradermal and epicutaneous
- Vehicle:
- other: physiological saline 0.9% NaCl ; vaseline
- Concentration / amount:
- For the intradermal injection (induction - first stage), 0.05 g of the test item was dissolved in physiological saline 0.9% NaCl
to gain a final volume of 10 mL of a 0.5% solution (w/v).
For the topical application (induction – second stage), 2.5 g of the test item were dissolved in vaseline
to gain a final weight of 10 g of a 25% solution (w/w). - Adequacy of induction:
- highest concentration used causing mild-to-moderate skin irritation and well-tolerated systemically
Challenge
- No.:
- #1
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: vaseline
- Concentration / amount:
- For the topical application (challenge), 0.2 g of the test item were dissolved in vaseline
to gain a final weight of 20 g of a 1% solution (w/w). - Day(s)/duration:
- 1
- Adequacy of challenge:
- not specified
- No. of animals per dose:
- 10 test animals and 5 control animals
- Details on study design:
- Induction: First Stage, Intradermal Injection
Three pairs of intradermal injections of 0.1 mL volume were given in the shoulder region which was cleared
of hair by clipping so that one of each pair lies on each side of the midline.
Test Group: Day 0
Injection 1: a 1:1 mixture (v/v) FCA/physiological saline 0.9% NaCl
Injection 2: a 0.5% concentration of the test item in physiological saline 0.9% NaCl
Injection 3: a 0.5% concentration of the test item formulated in a 1:1 mixture (v/v) FCA/physiological saline 0.9% NaCl
Negative-Control Group: Day 0
Injection 1: a 1:1 mixture (v/v) FCA/physiological saline 0.9% NaCl
Injection 2: 100% physiological saline 0.9% NaCl
Injection 3: a 50% (v/v) formulation of physiological saline 0.9% NaCl in a 1:1 (v/v) mixture FCA/physiological saline 0.9% NaCl
Positive-Control Group: Day 0
Injection 1: a 1:1 mixture (v/v) FCA/physiological saline 0.9% NaCl
Injection 2: 2% mercaptobenzothiazole in cottonseed oil
Injection 3: a 50% (v/v) formulation of 2% mercaptobenzothiazole in a 1:1 (v/v) mixture FCA/physiological saline 0.9% NaCl
Injections 1 and 2 were given close to each other and nearest to the head, while injection 3 was given toward the caudal part of the test area.
Induction: Second Stage, Topical Application
Test Group and Control Group: Day 6
Approximately twenty-four hours before the topical application the test area was close clipped.
Test Group: Day 7
The test item was dissolved in vaseline at a concentration of 25%. A patch was fully loaded with 0.5 g of
the prepared test item. Then it was applied to the test area and held in contact with the help of an occlusive dressing for 48 hours.
Negative-Control Group: Day 7
A patch was fully loaded with 0.5 g of vaseline. Then it was applied to the test area and held in contact with
the help of an occlusive dressing for 48 hours.
Positive-Control Group: Day 7
A patch was fully loaded with the positive-control substance at a concentration of 25%, applied to the test
area and held in contact by an occlusive dressing for 48 hours.
Challenge: Topical Application
The flanks of treated and control animals were cleared of hair by close-clipping.
Test Group and Control Group: Day 20
The test item was dissolved in vaseline at a concentration of 1%. A patch, loaded with 0.5 g of the prepared
test item was applied to the left flank of the animals and a patch loaded with 0.5 g of the vehicle to the right
flank (intraspecific control). The patches were held in contact with the help of an occlusive dressing for 24 hours.
Positive control group: day 20-22
A patch loaded with the positive-control substance at a concentration of 15% was applied to the left flank of the animals
and, a patch loaded with the vehicle to the right flank (intraspecific control), respectively. The patches were held in contact
by an occlusive dressing for 24 hours.
The application area was not rinsed. - Challenge controls:
- The flanks of treated and control animals were cleared of hair by close-clipping.
Test Group and Control Group: Day 20
The test item was dissolved in vaseline at a concentration of 1%. A patch, loaded with 0.5 g of the prepared test item was applied to the left flank of the animals and a patch loaded with 0.5 g of the vehicle to the right flank (intraspecific control).
The patches were held in contact with the help of an occlusive dressing for 24 hours.
Positive control group: day 20-22
A patch loaded with the positive-control substance at a concentration of 15% was applied to the left flank
of the animals and, a patch loaded with the vehicle to the right flank (intraspecific control), respectively.
The patches were held in contact by an occlusive dressing for 24 hours.
The application area was not rinsed. - Positive control substance(s):
- yes
- Remarks:
- 2-mercaptobenzothiazole
Results and discussion
- Positive control results:
- There was only evidence of sensitisation at the positive-control animals and the percentage of sensitised animals was 100%.
In vivo (non-LLNA)
Resultsopen allclose all
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 0,5 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- none
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 0,5 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- none
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- 15 %
- No. with + reactions:
- 5
- Total no. in group:
- 5
- Clinical observations:
- none
- Remarks on result:
- positive indication of skin sensitisation
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 0,5 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- no
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 15 %
- No. with + reactions:
- 5
- Total no. in group:
- 5
- Clinical observations:
- no
- Remarks on result:
- positive indication of skin sensitisation
Any other information on results incl. tables
Preliminary Test
1 animal was treated intradermally with concentrations of 5% and 2.5% of the test item (dissolved inphysiological saline 0.9% NaCl, AlleMan Pharma, lot no. 111036, expiry date: 09/2014).
1 animal was treated intradermally with concentrations of 1% and 0.5% of the test item (dissolved inphysiological saline 0.9% NaCl, AlleMan Pharma, lot no. 111036, expiry date: 09/2014).
1 animal was treated topically with concentrations of 100% and 50% of the test item (dissolved in vaseline, Euro OTC Pharma, lot no. 2912017-01, expiry date: 30/04/2013) for 24 hours.
1 animal was treated topically with concentrations of 100% and 50% of the test item (dissolved in vaseline, Euro OTC Pharma, lot no. 2912017-01, expiry date: 30/04/2013) for 48 hours.
1 animal was treated topically with concentrations of 25% and 12.5% of the test item (dissolved in vaseline, Euro OTC Pharma, lot no. 2912017-01, expiry date: 30/04/2013) for 24 hours.
1 animal was treated topically with concentrations of 25% and 12.5% of the test item (dissolved in vaseline, Euro OTC Pharma, lot no. 2912017-01, expiry date: 30/04/2013) for 48 hours.
1 animal was treated topically with concentrations of 6.25% and 3% of the test item (dissolved in vaseline, Euro OTC Pharma, lot no. 2912017-01, expiry date: 30/04/2013) for 48 hours.
1 animal was treated topically with concentrations of 6.25% and 3% of the test item (dissolved in vaseline, Euro OTC Pharma, lot no. 2912017-01, expiry date: 30/04/2013) for 24 hours.
1 animal was treated topically with concentrations of 2% and 1% of the test item (dissolved in vaseline, Euro OTC Pharma, lot no. 2912017-01, expiry date: 30/04/2013) for 24 hours.
Based on the results of this preliminary test, a concentration of 0.5% was chosen for the intradermal application of the main test and a concentration of 25% was selected for the dermal induction. These concentrations caused slight signs of irritation, without leading to systemic effects.
A concentration of 1% was found to be the highest dose which did not cause any signs of irritation after a topical treatment over a period of 24 hours and therefore was chosen for the challenge application in the main test.
Main Test
Signs of irritation during the induction:
Intradermal Induction I (24-hour reading):
Injection site 1: erythema
grade 1 in 5/5 negative- and positive-control and 10/10 test animals,
oedema grade 1 in 5/5
negative- and positive-control and 10/10 test animals
Injection site 2: erythema
grade 1 in 5/5 positive-control animals,
oedema grade 1 in 4/5
positive-control animals
Injection site 3: erythema
grade 1 in 5/5 negative- and positive-control and 10/10 test animals,
oedema grade 1 in 3/5
negative-control, 5/5 positive-control and 10/10 test animals
Intradermal Induction I (48-hour reading):
Injection site 1: erythema
grade 1 in 5/5 negative- and positive-control and 10/10 test animals,
oedema grade 1 in 5/5
negative- and positive-control and 10/10 test animals
Injection site 2: erythema
grade 1 in 5/5 positive-control animals,
oedema grade 1 in 5/5
positive-control animals
Injection site 3: erythema
grade 1 in 5/5 negative- and positive-control and 10/10 test animals,
oedema grade 1 in 3/5
negative-control, 5/5 positive-control and 10/10 test animals
Dermal Induction II (48-hour exposure, occlusive):
Immediately after removing the patch: no signs of irritation in any of the test or control animals
24 hours after removing the patch: no signs of irritation in any of the test or control animals
Challenge Exposure (24-hour exposure, occlusive):
Neither erythema nor oedema was observed in the negative-control and test animals at any observation time.
24 hours after removing the patch: Erythema grade 1 in 2 out of 5 positive-control animals and erythema grade 2 in 3 out of 5 positive-control animals at the test site.
48 hours after removing the patch: Erythema grade 1 in 2 out of 5 positive-control animals and erythema grade 2 in 3 out of 5 positive-control animals at the test site.
Eschar in 4 out 5 positive-control animals at the test site
Table3: Challenge Exposure
Challenge Concentrations of Test Substance: 1% |
||
|
Number of Animals Showing Skin Reactions after |
|
24 hours |
48 hours |
|
Test Group |
0 |
0 |
Negative-Control Group |
0 |
0 |
Positive-Control Group |
5 |
5 |
Body Weight Development
The body weight development was within the biological range for all animals compared to historical data.
All animals of the test and both control groups survived throughout the test period.Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Under the conditions of the present study it can be stated that the test item Genamin 3920 caused no reactions identified as
sensitisation at the tested concentration.
According to the EC criteria for classification and labelling requirements for dangerous substances and preparations (Guidelines in Commission Directive 2001/59/EC]) labelling is not necessary. - Executive summary:
On the basis of the test results given below and in conformity with the criteria given in Annex VI to Commission Directive 2001/59/EC the substance should be:
non skin sensitizing
Daily clinical observations of the animals did not reveal any visible clinical symptoms. No mortality occurred.
Species/strain: Crl: HA - Guinea Pigs
Number of animals (test group): 10
Number of animals (negative-control group): 5
Number of animals (positive-control group): 5
The following concentrations were determined by the preliminary test:
For each induction the highest concentration to cause mild-to-moderate skin irritation, but well tolerated systemically, were used as follows:
Intradermal induction: 0.5% of the test item, vehicle:physiological saline 0.9% NaCl
Dermal induction: 25% of the test item, vehicle: vaseline
Challenge exposure (highest non-irritating dose): 1% of the test item, vehicle: vaseline
During the induction slight signs of irritation were observed. Those findings corresponded to the results of the preliminary test and confirmed the validity of the study.
Challenge Exposure:
Neither erythema nor oedema was observed in the negative-control and test animals at any observation time.
24 hours after removing the patch:
Erythema grade 1 in 2 out of 5 positive-control animals and erythema grade 2 in 3 out of 5 positive-control animals at the test site.
48 hours after removing the patch:
Erythema grade 1 in 2 out of 5 positive-control animals and erythema grade 2 in 3 out of 5 positive-control animals at the test site.
Eschar in 4 out 5 positive-control animals at the test site.
There was only evidence of sensitisation at the positive-control animals for the challenge and the percentage of sensitised animals was 100%.
Table1: Challenge Exposure
Challenge Concentrations of Test Substance: 1%
Number of Animals Showing Skin Reactions after
24 hours
48 hours
Test Group
0
0
Negative-Control Group
0
0
Positive-Control Group
(15% concentration)5
5
Method (type of test): OECD 406
EC 440/2008
OPPTS 870.2600
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)